These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 7758502

  • 1. Clinical significance of technetium-99m methylene diphosphonate myocardial uptake: association with carcinoma of the prostate.
    al-Nahhas AM, Jinnouchi S, Anagnostopoulos C, Hirsch W, Heary T, McCready VR.
    Eur J Nucl Med; 1995 Feb; 22(2):148-53. PubMed ID: 7758502
    [Abstract] [Full Text] [Related]

  • 2. Soft-tissue uptake of technetium-99m-MDP after prostate cryoablation.
    Zucker I, Charkes ND, Seidmon EJ, Maurer AH.
    J Nucl Med; 1997 Apr; 38(4):525-8. PubMed ID: 9098195
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Cardiac involvement in systemic amyloidosis: myocardial scintigraphic evaluation].
    Hongo M, Yamada H, Okubo S, Hirayama J, Fujii T, Kusama S, Ikeda S.
    J Cardiogr; 1985 Mar; 15(1):163-80. PubMed ID: 2999267
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Bone scintigraphy with 99mTc-hydroxymethylene diphosphonate (HMDP)--comparison with 99mtc-MDP (author's transl)].
    Nakano S, Hasegawa Y, Shiomura K, Ibuka K, Hashizume T.
    Kaku Igaku; 1981 Dec; 18(10):1485-8. PubMed ID: 6210789
    [No Abstract] [Full Text] [Related]

  • 7. Increased technetium-99 m hydroxy diphosphonate soft tissue uptake on bone scintigraphy in chronic kidney disease patients with secondary hyperparathyroidism: correlation with hyperphosphataemia.
    Enevoldsen LH, Heaf J, Højgaard L, Zerahn B, Hasbak P.
    Clin Physiol Funct Imaging; 2017 Mar; 37(2):131-136. PubMed ID: 26148143
    [Abstract] [Full Text] [Related]

  • 8. Increased skeletal:renal uptake ratio: etiology and characteristics.
    Cheng TH, Holman BL.
    Radiology; 1980 Aug; 136(2):455-9. PubMed ID: 6447313
    [Abstract] [Full Text] [Related]

  • 9. Myocardial uptake of Tc-99m HDP in a patient with prostate carcinoma.
    Chadrawar S, George M, Al-Akraa M, Herber M, Buscombe J.
    Nucl Med Rev Cent East Eur; 2009 Aug; 12(2):78-80. PubMed ID: 20235058
    [Abstract] [Full Text] [Related]

  • 10. Etidronate therapy decreases the sensitivity of bone scanning with methylene diphosphonate labelled with technetium-99m.
    Murphy KJ, Line BR, Malfetano J.
    Can Assoc Radiol J; 1997 Jun; 48(3):199-202. PubMed ID: 9193420
    [Abstract] [Full Text] [Related]

  • 11. Soft tissue uptake on 99mTc methylene diphosphonate bone scan imaging: pictorial review.
    Kaye J, Hayward M.
    Australas Radiol; 2002 Mar; 46(1):13-21. PubMed ID: 11966582
    [Abstract] [Full Text] [Related]

  • 12. Extraosseous Tc-99m MDP uptake: a pathophysiologic approach.
    Peller PJ, Ho VB, Kransdorf MJ.
    Radiographics; 1993 Jul; 13(4):715-34. PubMed ID: 8356264
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A comparison between the diagnostic efficacy of 99mTc-MDP, 99mTc-DPD and 99mTc-HDP for the detection of bone metastases.
    Pauwels EK, Blom J, Camps JA, Hermans J, Rijke AM.
    Eur J Nucl Med; 1983 Jul; 8(3):118-22. PubMed ID: 6220908
    [Abstract] [Full Text] [Related]

  • 15. Technetium-99m MDP vs technetium-99m dicarboxypropane diphosphonate. A clinical comparison in various pathologic conditions.
    Godart G, Durez M, Bevilacqua M, Abramovici J, Robience Y.
    Clin Nucl Med; 1986 Feb; 11(2):92-7. PubMed ID: 3769350
    [Abstract] [Full Text] [Related]

  • 16. Significance of increased scrotal Tc-99m MDP uptake in patients with prostate cancer.
    Selcuk NA, Sayman HB, Kanmaz B, Turkmen C, Selcuk H, Nisli C, Uslu I.
    Nucl Med Commun; 2011 Feb; 32(2):155-8. PubMed ID: 21085045
    [Abstract] [Full Text] [Related]

  • 17. Relationship between 99Tcm-MDP uptake and bone mineral density in patients with prostatic carcinoma.
    Sundkvist GM, Nilsson M, Ahlgren L, Lilja B, Mattsson S, Birch-Iensen M, Abrahamsson PA.
    Nucl Med Commun; 1991 Jul; 12(7):629-36. PubMed ID: 1923154
    [Abstract] [Full Text] [Related]

  • 18. Which diphosphonate for routine bone scintigraphy (MDP, HDP or DPD)?
    Frühling J, Verbist A, Balikdjian D.
    Nucl Med Commun; 1986 Jun; 7(6):415-25. PubMed ID: 3748485
    [Abstract] [Full Text] [Related]

  • 19. Myocardial and vascular uptake of a bone tracer associated with secondary hyperparathyroidism.
    Kida T, Hujita Y, Sasaki M, Inoue J.
    Eur J Nucl Med; 1986 Jun; 12(3):151-4. PubMed ID: 3758104
    [Abstract] [Full Text] [Related]

  • 20. Additional information from quantitative 24-hour 99mTc-MDP bone scintigraphy in patients with prostatic carcinoma.
    Sundkvist GM, Ahlgren L, Lilja B, Mattsson S.
    Acta Oncol; 1991 Jun; 30(5):635-9. PubMed ID: 1892682
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.